Elevation of (Pro)Renin and (Pro)renin receptor in preeclampsia

American Journal of Hypertension

Volumn 28, Issue 10, 2015, Pages 1277-1284

  Thomason, Jessica ^a   Reyes, Michelle ^b   Allen, Steven R ^b   Jones, Richard O ^b   Beeram, Madhava R ^a   Kuehl, Thomas J ^a,b   Suzuki, Fumiaki ^c   Uddin, Mohammad Nasir ^a,b,d  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Obstetrics and Gynecology Practice   (United States)

^c GIFU UNIVERSITY   (Japan)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

(pro) renin; (pro)renin receptor; blood pressure; hypertension; placenta; preeclampsia; renin angiotensin system

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; PRORENIN; PRORENIN RECEPTOR; CELL SURFACE RECEPTOR; RENIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; NONHUMAN; PATHOGENESIS; PLACENTA TISSUE; PLASMA RENIN ACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; URINALYSIS; ADOLESCENT; ANIMAL; BLOOD; CASE CONTROL STUDY; DISEASE MODEL; KIDNEY; METABOLISM; PLACENTA; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS; RECEPTORS, CELL SURFACE; RENIN; UP-REGULATION; YOUNG ADULT;

EID: 84943645464     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv019     Document Type: Conference Paper

References (43)

1. Ianosi-Irimie M, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, Wrenn DC, Pridjian G, Puschett JB. A rat model of preeclampsia. Clin Exp Hypertens 2005; 8:605-617.
2. Pridjian G, Puschett JB. Preeclampsia, Part I: clinical and pathophysiological considerations. Obstet Gynecol Surv 2002; 57:598-618.
3. World Health Organization. Maternal Mortality in 2000 Maternal Mortality in 2000; Estimates Developed by WHO, UNICEF and UNFPA World Health Organization, 2004.
4. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 65:497-506.
5. Shah DM. Role of the renin-Angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 2005; 288:F614-F625.
6. Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002; 18:239-245.
7. Anton L, Merrill DC, Neves LA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 2008; 51:1066-1072.
8. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB. The uterine placental bed renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology 2009; 150:4316-4325.
9. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update 2010; 16:415-431.
10. Brown MA, Zammit VC, Mitar DA, Whitworth JA. Renin-Aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens 1992; 5:366-371.
11. Morris BJ. Molecular biology of renin. I: gene and protein structure, synthesis and processing. J Hypertens 1992; 10:209-214.
12. Cooper AC, Robinson G, Vinson GP, Cheung WT, Pipkin FB. The localization and expression of the renin-Angiotensin system in the human placenta throughout pregnancy. Placenta 1999; 20:467-474.
13. Xia Y, Wen H, Prashner HR, Chen R, Inagami T, Catanzaro DF, Kellems RE. Pregnancy-induced changes in renin gene expression in mice. Biol Reprod 2002; 66:135-143.
14. Nielsen AH, Schauser KH, Poulsen K. The uteroplacental renin-Angiotensin system. Placenta 2000; 21:468-477.
15. Brar HS, Kjos SL, Dougherty W, Do YS, Tam HB, Hsueh WA. Increased fetoplacental active renin production in pregnancy-induced hypertension. Am J Obstet Gynecol 1987; 157:363-367.
16. Ito M, Itakura A, Ohno Y, Nomura M, Senga T, Nagasaka T, Mizutani S. Possible activation of the renin-Angiotensin system in the feto-placental unit in preeclampsia. J Clin Endocrinol Metab 2002; 87:1871-1878.
17. Uddin MN, Nabi AH, Nakagawa T, Ichihara A, Inagami T, Suzuki F. Non-proteolytic activation of prorenin: activation by (pro)renin receptor and its inhibition by a prorenin prosegment, decoy peptide. Front Biosci 2008; 13:745-753.
18. Nabi AH, Uddin NM, Nakagawa T, Iwata H, Ichihara A, Inagami T, Suzuki F. Role of "handle" region of prorenin prosegment in the nonproteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci 2007; 12:4810-4817.
19. Suzuki F, Hayakawa M, Nakagawa T, Uddin MN, Ebihara A, Iwasawa A, Ishida Y, Nakamura Y, Kazuo M. Human Prorenin Has "Gate and Handle" Regions for Its Non-proteolytic Activation. J Biol Chem 2003; 278:22217-22222.
20. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 2004; 114:1128-1135.
21. Watanabe N, Bokuda K, Fujiwara T, Suzuki T, Mito A, Morimoto S, Jwa SC, Egawa M, Arai Y, Suzuki F, Sago H, Ichihara A. Soluble (pro)renin receptor and blood pressure during pregnancy: a prospective cohort study. Hypertension 2012; 60:1250-1256.
22. Uddin MN, Takahashi K, Nagai T, Nakagawa T, Suzuki F, Nakamura Y. Two peaks in pH dependence of renin-Angiotensinogen reaction. Biosci Biotechnol Biochem 1998; 62:338-340.
23. Uddin MN, Iwanaga S, Nabi AH, Urayama O, Hayashi K, Hayashi T, Kawai K, Sultana A, Murakami K, Suzuki F. Laughter therapy modulates the parameters of renin-Angiotensin system in patients with type 2 diabetes. Int J Mol Med 2005; 16:1077-1081.
24. Uddin MN, McLean LB, Hunter FA, Horvat D, Severson J, Tharakan B, Childs EW, Puschett JB. Vascular leak in a rat model of preeclampsia. Am J Nephrol 2009; 30:26-33.
25. Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab 1992; 75:906-910.
26. Singh HJ, Rahman A, Larmie ET, Nila A. Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation. Placenta 2004; 25:631-636.
27. Kalenga MK, Thomas K, de Gasparo M, De Hertogh R. Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol (Oxf) 1996; 44:429-433.
28. Kataoka K, Kurokawa N, Yanaihara C, Takahara S, Okuyama A, Yanaihara N. Prorenin and renin in human tissues and plasma-immunochemical identification. Immunopharmacology 1996; 32:146-148.
29. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427.
30. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-Angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 1993; 91:2058-2064.
31. Lenz T. Prorenin and active renin in human fetal circulation. Acta Obstet Gynecol Scand 1996; 75:291-293.
32. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F, Damm P, Mathiesen ER. A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes. Diabetologia 2011; 54:1615-1619.
33. Uddin MN, Agunanne E, Horvat D, Puschett JB. Alterations in the renin-Angiotensin system in a rat model of human preeclampsia. Am J Nephrol 2010; 31:171-177.
34. Pringle KG, Tadros MA, Callister RJ, Lumbers ER. The expression and localization of the human placental prorenin/renin-Angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?. Placenta 2011; 32:956-962.
35. Marques FZ, Pringle KG, Conquest A, Hirst JJ, Markus MA, Sarris M, Zakar T, Morris BJ, Lumbers ER. Molecular characterization of renin-Angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section. Placenta 2011; 32:214-221.
36. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, Nakagawa T, Nishiyama A, Suzuki F, Inagami T, Itoh H. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro) renin receptor-Transgenic rats. J Am Soc Nephrol 2007; 18:1789-1795.
37. Hirose T, Hashimoto M, Totsune K, Metoki H, Asayama K, Kikuya M, Sugimoto K, Katsuya T, Ohkubo T, Hashimoto J, Rakugi H, Takahashi K, Imai Y. Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study. Am J Hypertens 2009; 22:294-299.
38. Ott C, Schneider MP, Delles C, Schlaich MP, Hilgers KF, Schmieder RE. Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men. Pharmacogenet Genomics 2010; 21:347-349.
39. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, Ingelfinger D, Boutros M, Niehrs C. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010; 327:459-463.
40. Derkx FH, Alberda AT, de Jong FH, Zeilmaker FH, Makovitz JW, Schalekamp MA. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J Clin Endocrinol Metab 1987; 65:349-354.
41. Yoshikawa A, Aizaki Y, Kusano K, Kishi F, Susumu T, Iida S, Ishiura S, Nishimura S, Shichiri M, Senbonmatsu T. The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Hypertens Res 2011; 34:599-605.
42. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptormediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69:105-113.
43. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, Nabi AH, Nishiyama A, Sugaya T, Hayashi M, Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006; 17:1950-1961.